Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
Manuel Cuenca‐Estrella(Instituto de Salud Carlos III), J. L. Rodríguez-Tudela(Unknown), Paul E. Verweij(Radboud University Nijmegen), Malcolm Richardson, Françoise Dromer(Institut Pasteur), Francesco Barchiesi(Marche Polytechnic University), B. Dupont(Délégation Paris 5), Banu Sancak, Erja Chryssanthou(Karolinska University Hospital), David W. Denning(Manchester Academic Health Science Centre), Jacques Billé(University Hospital of Lausanne), Caroline B. Moore(University of Manchester), J. Peter Donnelly(Baylor College of Medicine), John Rex(Princeton University)
Cited by 159
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k